SCHEMBL21614716

SCHEMBL21614716

COc1ncc(-c2nc(CNc3ccnc(C(F)(F)F)c3)cs2)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 3/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ IDH1 O75874 3/20 0.41
▸ CYP3A4 P08684 2/20 0.39
▸ RHOC P08134 1/20 0.38
▸ RHOA P61586 1/20 0.38
▸ SRC P12931 2/20 0.38
▸ ZAP70 P43403 2/20 0.38
▸ SYK P43405 2/20 0.38
▸ RAF1 P04049 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ EPHA2 P29317 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ EPHB4 P54760 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ LRRK2 Q5S007 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21614717 0.83 TP53 (0.50) CYP2C19CYP2C9CYP3A4SRCZAP70
SCHEMBL21612034 0.83 CYP2C19 (0.49) CYP2C19CYP2C9CYP3A4RAF1CYP1A2
SCHEMBL21612017 0.81 CYP2C19 (0.71) CYP2C19CYP2C9IDH1CYP3A4RHOC
SCHEMBL21614721 0.77 CYP2C19 (0.51) CYP2C19CYP2C9IDH1CYP3A4RHOC
SCHEMBL21612036 0.76 CYP2C19 (0.52) CYP2C19CYP2C9IDH1CYP3A4RHOC
SCHEMBL21612013 0.76 CYP2C19 (0.61) CYP2C19CYP2C9IDH1CYP3A4RHOC
SCHEMBL21614718 0.75 SYK (0.42) CYP2C19CYP2C9IDH1CYP3A4RHOC
SCHEMBL21612023 0.75 IDH1 (0.46) CYP2C19CYP2C9IDH1CYP3A4RHOC
SCHEMBL21614741 0.75 CYP2C19 (0.55) CYP2C19CYP2C9CYP3A4TP53MAPT
SCHEMBL21614728 0.74 CYP2C19 (0.57) CYP2C19CYP2C9IDH1CYP3A4SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 CYP2C19 1824/4885CYP2C9 2997/4885IDH1 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback